Related references
Note: Only part of the references are listed.Animal Models of Serotonergic Psychedelics
James B. Hanks et al.
ACS CHEMICAL NEUROSCIENCE (2013)
'Distorteidolias' - Fantastic Perceptive Distortion A New, Pure Dorsomedial Thalamic Syndrome
Montserrat G. Delgado et al.
EUROPEAN NEUROLOGY (2013)
Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects
Carolina Muguruza et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Prenatal Stress Induces Schizophrenia-Like Alterations of Serotonin 2A and Metabotropic Glutamate 2 Receptors in the Adult Offspring: Role of Maternal Immune System
Terrell Holloway et al.
JOURNAL OF NEUROSCIENCE (2013)
Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
Michael Kometer et al.
JOURNAL OF NEUROSCIENCE (2013)
Altered Reward Circuitry in the Norepinephrine Transporter Knockout Mouse
Joseph J. Gallagher et al.
PLOS ONE (2013)
Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism
Natalia V. Malkova et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia
H. Y. Meltzer et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism
Alan S. Brown
DEVELOPMENTAL NEUROBIOLOGY (2012)
Deletion of PLCB1 gene in schizophrenia-affected patients
Vincenza Rita Lo Vasco et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
An anatomically comprehensive atlas of the adult human brain transcriptome
Michael J. Hawrylycz et al.
NATURE (2012)
Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI
Joseph J. Gallagher et al.
NEUROIMAGE (2012)
To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models
Urs Meyer et al.
NEUROPHARMACOLOGY (2012)
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
Boris B. Quednow et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Quantitative pharmacologic MRI in mice
Teodora-Adriana Perles-Barbacaru et al.
NMR IN BIOMEDICINE (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia
Bin Tang et al.
PSYCHIATRY RESEARCH (2012)
Cognition in schizophrenia: core psychological and neural mechanisms
Deanna M. Barch et al.
TRENDS IN COGNITIVE SCIENCES (2012)
Phospholipase C beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness
Madhara Udawela et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2011)
Postnatal Serotonin Type 2 Receptor Blockade Prevents the Emergence of Anxiety Behavior, Dysregulated Stress-Induced Immediate Early Gene Responses, and Specific Transcriptional Changes that Arise Following Early Life Stress
Madhurima Benekareddy et al.
BIOLOGICAL PSYCHIATRY (2011)
Serotonin 2A receptor antagonists for treatment of schizophrenia
Bjorn H. Ebdrup et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT2A and mGlu2 Receptors in the Adult Offspring
Jose L. Moreno et al.
JOURNAL OF NEUROSCIENCE (2011)
Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development
Evelyn K. Lambe et al.
PLOS ONE (2011)
Schizophrenia and Autism: Both Shared and Disorder-Specific Pathogenesis Via Perinatal Inflammation?
Urs Meyer et al.
PEDIATRIC RESEARCH (2011)
Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine
Hans Rasmussen et al.
PSYCHOPHARMACOLOGY (2011)
Neural Mechanisms of Impaired Fear Inhibition in Posttraumatic Stress Disorder
Tanja Jovanovic et al.
Frontiers in Behavioral Neuroscience (2011)
Enhanced Function of Prefrontal Serotonin 5-HT2 Receptors in a Rat Model of Psychiatric Vulnerability
Madhurima Benekareddy et al.
JOURNAL OF NEUROSCIENCE (2010)
Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia
Byron K. Y. Bitanihirwe et al.
NEUROPSYCHOPHARMACOLOGY (2010)
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
Adam L. Halberstadt et al.
PSYCHOPHARMACOLOGY (2010)
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models
Paul H. Patterson
BEHAVIOURAL BRAIN RESEARCH (2009)
Group II metabotropic glutamate receptors and schizophrenia
Jose L. Moreno et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia
Christine Winter et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders
Urs Meyer et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
Statistical mapping of sound-evoked activity in the mouse auditory midbrain using Mn-enhanced MRI
Xin Yu et al.
NEUROIMAGE (2008)
Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions
Mark J. Millan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Maternal immune activation alters fetal brain development through interleukin-6
Stephen E. P. Smith et al.
JOURNAL OF NEUROSCIENCE (2007)
Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics
Eva Romero et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane
Efrain E. Garcia et al.
NEUROPHARMACOLOGY (2007)
Cocaine-induced brain activation detected by dynamic manganese-enhanced magnetic resonance imaging (MEMRI)
Hanbing Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
Prefrontal cortex and insight in schizophrenia: A volumetric MRI study
Adegboyega Sapara et al.
SCHIZOPHRENIA RESEARCH (2007)
Allele C-specific methylation of the 5-HT2A receptor gene:: Evidence for correlation with its expression and expression of DNA methylase DNMT1
OO Polesskaya et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
In vivo auditory brain mapping in mice with Mn-enhanced MRI
X Yu et al.
NATURE NEUROSCIENCE (2005)
Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring
L Zuckerman et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
Generation and characterization of Rgs4 mutant mice
N Grillet et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
BDNF in schizophrenia, depression and corresponding animal models
F Angelucci et al.
MOLECULAR PSYCHIATRY (2005)
Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain:: role in learned helplessness behavior
Y Dwivedi et al.
NEUROPHARMACOLOGY (2005)
Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors
H Weinstein
AAPS JOURNAL (2005)
Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex
M Amargós-Bosch et al.
CEREBRAL CORTEX (2004)
Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to image brain plasticity in song birds
A Van der Linden et al.
NMR IN BIOMEDICINE (2004)
Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations
AC Silva et al.
NMR IN BIOMEDICINE (2004)
In vivo, trans-synaptic tract-tracing utilizing manganese-enhanced magnetic resonance imaging (MEMRI)
RG Pautler
NMR IN BIOMEDICINE (2004)
Monamine oxidase and head-twitch response in mice mechanisms of alpha-methylated substrate derivatives
O Nakagawasai et al.
NEUROTOXICOLOGY (2004)
Functions of 5-HT2A receptor and its antagonists in the cardiovascular system
T Nagatomo et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Serotonin receptors : their key role in drugs to treat schizophrenia
HY Meltzer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Energy metabolism in astrocytes and neurons treated with manganese: Relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis
C Zwingmann et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Cellular regulation of RGS proteins: Modulators and integrators of G protein signaling
S Hollinger et al.
PHARMACOLOGICAL REVIEWS (2002)
Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging
RG Pautler et al.
NEUROIMAGE (2002)
Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: Implications for genesis of autism and schizophrenia
SH Fatemi et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2002)
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
K Mirnics et al.
MOLECULAR PSYCHIATRY (2001)
Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors: Ontogeny and strain differences
M Farid et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Cyclooxygenases in the central nervous system: Implications for treatment of neurological disorders
A Yermakova et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients
M Takahashi et al.
MOLECULAR PSYCHIATRY (2000)
Share Paper
